UBS Group AG - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$1,311,482
+412.0%
23,954
+685.4%
0.00%
Q2 2023$256,139
-76.4%
3,050
-78.7%
0.00%
Q1 2023$1,085,665
+78.3%
14,336
+45.3%
0.00%
Q4 2022$608,806
+375.6%
9,864
+220.5%
0.00%
Q3 2022$128,000
+11.3%
3,078
-15.8%
0.00%
Q2 2022$115,000
-68.7%
3,654
-73.2%
0.00%
Q1 2022$367,000
-24.5%
13,643
-46.1%
0.00%
Q4 2021$486,000
+386.0%
25,335
+737.5%
0.00%
Q3 2021$100,000
+28.2%
3,025
+28.7%
0.00%
Q2 2021$78,000
-47.3%
2,350
-33.8%
0.00%
Q1 2021$148,000
-19.6%
3,549
-61.7%
0.00%
Q4 2020$184,000
+73.6%
9,278
+20.0%
0.00%
Q3 2020$106,000
-56.6%
7,730
-43.2%
0.00%
Q2 2020$244,000
+39.4%
13,618
-6.2%
0.00%
Q1 2020$175,000
-59.7%
14,514
-36.5%
0.00%
Q4 2019$434,000
+59.0%
22,844
+98.7%
0.00%
Q3 2019$273,000
+38.6%
11,496
+69.2%
0.00%
Q2 2019$197,0006,7960.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 923,221$30,632,0005.64%
Sandhill Capital Partners LLC 1,429,432$47,429,0003.70%
Bullseye Asset Management LLC 117,471$3,898,0001.31%
Taylor Wealth Management Partners 72,685$2,412,0000.85%
Signature Wealth Management Partners, LLC 14,000$465,0000.42%
EMERALD MUTUAL FUND ADVISERS TRUST 369,259$12,252,0000.40%
Triumph Capital Management 20,051$622,0000.36%
EMERALD ADVISERS, LLC 300,464$9,969,0000.36%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,347$2,533,0000.30%
Bellevue Group AG 729,989$24,221,0000.24%
View complete list of TRANSMEDICS GROUP INC shareholders